Skip to main content
Byron Hoogwerf, MD, Endocrinology, Sarasota, FL

ByronJHoogwerfMD

Endocrinology Sarasota, FL

Diabetes, Lipid Metabolism

Clinical Research Physician

Dr. Hoogwerf is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hoogwerf's full profile

Already have an account?

Summary

  • I am a retired endocrinologist whose career has included 30 years in academic clinical settings (University of MN and the Cleveland Clinic) focused on patient care and clinical trials in diabetes and cardiovascular disease. I then spent 8 1/2 years at Eli Lilly in the Diabetes Business unit working in diabetes drug development. I have set up a personal consulting company called "High Doc Consulting" with a focus on drug development and medical writing.

Education & Training

  • University of Minnesota at Fairview
    University of Minnesota at FairviewFellowship, Endocrinology, Diabetes and Metabolism, 1978 - 1981
  • Hennepin County Medical Center
    Hennepin County Medical CenterResidency, Internal Medicine, 1976 - 1978
  • Hennepin County Medical Center
    Hennepin County Medical CenterInternship, Transitional Year, 1971 - 1972
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 1971
  • Calvin CollegeBA, Biology/Chemistry, 1967

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2018 - 2023
  • OH State Medical License
    OH State Medical License 1985 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Laureate Award American College of Physicians, Ohio Chapter, 2005
  • Endocrinology Teacher of the Year 2005
  • Laureate Teacher Cleveland Clinic Foundation, 2005
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Risk Factors for 30-Day Readmission Following Hypoglycemia-Related Emergency Room and Inpatient Admissions  
    Emons MF, Bae JP, Hoogwerf BJ, Kindermann SL, Taylor RJ, Nathanson BH, BMJ Open Diab Res Care, 1/1/2016
  • Major Adverse Cardiovascular Events with Basal Insulin Peglispro versus Comparator Insulins in Patients with Type 1 or Type 2 Diabetes: a meta-analysis  
    Hoogwerf BJ, Lincoff AM, Rodriguez A, Chen L, Qu Y., Cardiovascular Diabetology., 1/1/2016
  • Perspectives on some controversies in cardiovascular disease risk assessment in the pharmaceutical development of glucose lowering medications  
    Hoogwerf, BJ, Manner, DH, Fu, H, Moscarelli, E, Gaydos, BL, Heine, R, Diabetes Care, 1/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Authored Content

  • Research Updates from ADA 2021July 2021
  • Diabetes Mellitus: What’s New in the Diabetes LandscapeJune 2020
  • Diabetes Mellitus: What’s New in the Diabetes LandscapeJune 2020

Professional Memberships